Antiviral drugs could help us fight the new coronavirus, but currently, we don’t have a highly potent, effective antiviral that cures COVID-19. Why not? We called a few virologists to find out.
- Sources:
- Gilead's remdesivir gets emergency use authorization based on preliminary data in COVID-19
- Cell studies suggest some repurposed drugs could block replication of SARS-CoV-2
- How big pharma firms are quietly collaborating on new coronavirus antivirals
- All interventional SARS-CoV-2 trials registered on clinicaltrials.gov
- Antivirals Lecture
- Pulmonary critical care series on COVID treatment - Part 1
- Pulmonary critical care series on COVID treatment - Part 2
- Coronavirus therapeutics
- Remdesivir
;void(0);){kind=link}